# Transit Analysis for Shuttle Schedule Optimization

Canonical: https://abierto.us/opportunities/75f40124r00117

- Solicitation number: 75F40124R00117
- Notice type: Special notice
- Status: Closed. Deadline was June 17, 2024 at 12:00 PM EDT
- Department: Department of Health and Human Services
- Agency: Food and Drug Administration
- Contracting office: Food and Drug Administration (n-FOODANDDRUGADMINISTRATION)
- NAICS: 485113 Bus and Other Motor Vehicle Transit Systems
- Product or service code: AS11 Transportation R&D Services; Surface Transportation, Public Transit, And Rail; Basic Research
- Set-aside: Total small business set-aside
- Place of performance: Silver Spring, Maryland
- County: Montgomery County (FIPS 24031). https://abierto.us/counties/montgomery-county-md-24031
- City: Silver Spring. https://abierto.us/cities/silver-spring-md-2472450
- First posted: June 5, 2024
- Last posted: June 5, 2024
- SAM.gov: https://sam.gov/workspace/contract/opp/108502d51e3e4a719b7be5f25c0c529e/view

## Description

Notice of Fair Opportunity Small Business Set Aside - After Exclusion of Sources The US Food and Drug Administration {FDA), Office of Finance Budget Acquisition and Planning, intends to issue a single award from a fair opportunity competition After Exclusion of Sources; to conduct an analysis of all relevant transit options within the FDA White Oak Campus service area, located at 10903 New Hampshire Ave, Silver Spring, Maryland 20993; to update and modify FDA Commuter and Circulator Shuttle Bus schedules servicing the White Oak Campus; based on the results of the analysis with the objective of supplementing the services provided by local public transit agencies; and to provide for service where there are gaps in service provided by public transit agencies.

The propose this acquisition under the exclusion of sources, is for the Government to solicit and negotiate with identified source only. Interested parties may identify their interests and capabilities to respond to the requirement within seven (7) days after the publication of this notice.

A determination by the Government not to compete this proposed acquisition, other than Small Business Set Aside - After Exclusion of Sources, based upon responses to this notice, is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining, not to conduct a set aside competitive requirement. No further solicitation is available.

FDA will consider all responses received prior to the closing date of this notice and will use responses in determining, whether it is necessary to use full and open competition for this requirement. Responses shall be emailed to Natapol Sirikhan, Natapol.Sirikhan@fda.hhs.gov, by June 17, 2024, 12:00 PM EST.

## Publications

- June 5, 2024: Special notice, due June 17, 2024 at 12:00 PM EDT. Notice 108502d51e3e4a719b7be5f25c0c529e. https://sam.gov/workspace/contract/opp/108502d51e3e4a719b7be5f25c0c529e/view

## Points of contact

- Natapol Sirikhan, Natapol.Sirikhan@fda.hhs.gov, 240-402-8031

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/75f40124r00117.